id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-P-0155-0001,FDA,FDA-2001-P-0155,"FDA/DDM to Arnall, Golden Gregory",Other,ACK-Acknowledgement Letter,2001-12-27T05:00:00Z,2001,12,,,2008-04-25T02:27:48Z,,0,0,09000064804df043
FDA-2001-P-0053-0001,FDA,FDA-2001-P-0053,"Acknowledgment Letter from FDA DMB to Wilmer, Cutler & Pickering",Other,Acknowledgement Letter/Receipt,2001-12-27T05:00:00Z,2001,12,,,2024-09-23T22:37:14Z,,0,0,09000064804b7e38
FDA-2001-P-0452-0001,FDA,FDA-2001-P-0452,Approval Letter from FDA CDER to AA1 International,Other,Approval,2001-12-17T05:00:00Z,2001,12,2021-01-28T05:00:00Z,,2021-02-01T17:19:08Z,,0,0,0900006484a0af87
FDA-2001-P-0191-0001,FDA,FDA-2001-P-0191,"FDA/DDM to Hogan & Hartson, LLP",Other,ACK-Acknowledgement Letter,2001-12-11T05:00:00Z,2001,12,,,2008-04-25T02:25:58Z,,0,0,09000064804e2665
FDA-2001-P-0215-0002,FDA,FDA-2001-P-0215,"Acknowledgment Letter from FDA DMB to Omega Laboratories, Ltd.",Other,ACK-Acknowledgement Letter,2001-12-07T05:00:00Z,2001,12,,,2024-08-23T13:49:30Z,,0,0,09000064804e488d
FDA-2001-P-0086-0002,FDA,FDA-2001-P-0086,FDA/OC  to Washington Legal Foundation,Other,LET-Letter,2001-11-27T05:00:00Z,2001,11,,,2008-04-25T02:23:19Z,,0,0,09000064804b8543
FDA-1978-N-0018-0440,FDA,FDA-1978-N-0018,"Memorandum of Meeting Between FDA/OCC and Cosmetic, Toiletry and Fragrance Association",Other,Memorandum,2001-11-19T05:00:00Z,2001,11,,,2019-08-07T12:11:46Z,,0,0,090000648055a7fe
FDA-1980-N-0074-0075,FDA,FDA-1980-N-0074,FDA/ORA to Colgate-Palmolive Company,Other,PDN-Petition Denial,2001-11-14T05:00:00Z,2001,11,,,2008-05-30T22:52:47Z,,0,0,09000064805bb4db
FDA-2018-D-4115-0013,FDA,FDA-2018-D-4115,The Mammography Quality Standards Act Final Regulations: Preparing For MQSA Inspections; Final Guidance for Industry and FDA,Other,Guidance,2001-11-04T05:00:00Z,2001,11,2001-11-04T05:00:00Z,,2024-11-06T23:36:50Z,,1,0,0900006484644a3f
FDA-2001-P-0239-0005,FDA,FDA-2001-P-0239,"Letter from FDA CFSAN to Krislov & Associates, LTD.",Other,Letter(s),2001-10-31T05:00:00Z,2001,10,2020-07-06T04:00:00Z,,2024-09-09T17:22:16Z,,0,0,09000064804e6814
FDA-2001-P-0239-0004,FDA,FDA-2001-P-0239,Letter from FDA CFSAN to Center for Food Safety,Other,Letter(s),2001-10-31T05:00:00Z,2001,10,2020-07-06T04:00:00Z,,2024-09-09T17:22:06Z,,0,0,09000064804e6812
FDA-1999-P-0059-0004,FDA,FDA-1999-P-0059,FDA/DMB to Health Care Without Harm,Other,ACK-Acknowledgement Letter,2001-10-05T04:00:00Z,2001,10,,,2008-04-25T00:13:56Z,,0,0,09000064804a671c
FDA-1996-P-0041-0001,FDA,FDA-1996-P-0041,"Memorandum from FDA, Dave Read (HFD-7) to FDA Dockets Management Branch (HFA-305)",Other,Memorandum,2001-09-19T04:00:00Z,2001,9,,,2024-06-20T14:22:26Z,,0,0,09000064804fc5e9
FDA-2001-E-0027-0001,FDA,FDA-2001-E-0027,FDA/CDER to the U. S. Patent & Trademark Office - Letter,Other,LET-Letter,2001-09-12T04:00:00Z,2001,9,,,2010-01-29T15:43:16Z,,0,0,09000064804b5c4f
FDA-2001-P-0216-0002,FDA,FDA-2001-P-0216,"FDA/CDER to Paul, Hastings, Janofsky & Walker LLP",Other,LET-Letter,2001-09-11T04:00:00Z,2001,9,,,2008-04-25T02:38:56Z,,0,0,09000064804e4a25
FDA-1999-P-0059-0003,FDA,FDA-1999-P-0059,FDA/CDRH to Sanford J. Lewis,Other,PDN-Petition Denial,2001-09-11T04:00:00Z,2001,9,,,2008-04-25T00:13:56Z,,0,0,09000064804a671a
FDA-2001-P-0001-0002,FDA,FDA-2001-P-0001,FDA/CDER to Mutual Pharmaceutical Company,Other,LET-Letter,2001-09-11T04:00:00Z,2001,9,,,2008-04-25T02:25:38Z,,0,0,09000064804b3acf
FDA-2001-P-0056-0003,FDA,FDA-2001-P-0056,FDA/CDER to Pharmaceutical Associates Inc,Other,PAV-Petition Approval,2001-08-27T04:00:00Z,2001,8,,,2008-04-25T01:57:35Z,,0,0,09000064804b7ec8
FDA-2001-P-0239-0003,FDA,FDA-2001-P-0239,"Amendment from Krislov & Associates, LTD.",Other,Amendment,2001-08-23T04:00:00Z,2001,8,2020-07-06T04:00:00Z,,2020-07-06T22:32:12Z,,0,0,09000064804e680f
FDA-1999-N-0113-0168,FDA,FDA-1999-N-0113,"Draft Agenda for March 20, 2001 meeting",Other,LST-List,2001-08-03T04:00:00Z,2001,8,,,2008-04-25T00:17:47Z,,0,0,09000064804ae795
FDA-1999-N-0134-0009,FDA,FDA-1999-N-0134,HHS/USDA Action Plan,Other,TS-Testimony,2001-08-03T04:00:00Z,2001,8,,,2008-04-25T00:16:59Z,,0,0,09000064804aebb5
FDA-1999-N-0113-0169,FDA,FDA-1999-N-0113,Summary of the Draft Risk Assessment,Other,TS-Testimony,2001-08-03T04:00:00Z,2001,8,,,2008-04-25T00:17:45Z,,0,0,09000064804ae798
FDA-1999-N-0134-0007,FDA,FDA-1999-N-0134,Listeriosis in the United States,Other,TS-Testimony,2001-08-03T04:00:00Z,2001,8,,,2008-04-25T00:17:00Z,,0,0,09000064804aebb3
FDA-1999-N-0134-0006,FDA,FDA-1999-N-0134,"Agenda for March 19, 2001 Public Meeting",Other,LST-List,2001-08-03T04:00:00Z,2001,8,,,2008-04-25T00:17:00Z,,0,0,09000064804aebb2
FDA-1999-N-0134-0008,FDA,FDA-1999-N-0134,Draft Assessment of the Relative Risk,Other,TS-Testimony,2001-08-03T04:00:00Z,2001,8,,,2008-04-25T00:16:58Z,,0,0,09000064804aebb4
FDA-1999-N-0113-0170,FDA,FDA-1999-N-0113,Risk Reduction Strategy for Vibrio parahaemolyticus,Other,TS-Testimony,2001-08-03T04:00:00Z,2001,8,,,2008-04-25T00:17:41Z,,0,0,09000064804ae79b
FDA-2001-P-0190-0001,FDA,FDA-2001-P-0190,FDA/DDM to Washington Legal Foundation,Other,ACK-Acknowledgement Letter,2001-08-01T04:00:00Z,2001,8,,,2008-04-25T02:27:37Z,,0,0,09000064804e2531
FDA-2001-P-0156-0002,FDA,FDA-2001-P-0156,FDA/CDER to Tom Stothoff,Other,LET-Letter,2001-07-27T04:00:00Z,2001,7,,,2008-04-25T02:25:53Z,,0,0,09000064804df2a0
FDA-2001-P-0152-0001,FDA,FDA-2001-P-0152,FDA/DDM,Other,ACK-Acknowledgement Letter,2001-07-25T04:00:00Z,2001,7,,,2008-04-25T02:27:08Z,,0,0,09000064804ddd42
FDA-2001-P-0126-0001,FDA,FDA-2001-P-0126,"FDA/DDM to TestoCreme, LLC",Other,ACK-Acknowledgement Letter,2001-07-13T04:00:00Z,2001,7,,,2008-04-25T02:27:41Z,,0,0,09000064804dd948
FDA-2000-P-0151-0002,FDA,FDA-2000-P-0151,FDA/CFSAN to Sartori Food Corp.,Other,LET-Letter,2001-07-11T04:00:00Z,2001,7,,,2008-04-25T01:31:51Z,,0,0,09000064804d117f
FDA-1980-N-0074-0073,FDA,FDA-1980-N-0074,"FDA/ORA to Hyman, Phelps & McNamara, P. C.",Other,PDN-Petition Denial,2001-07-09T04:00:00Z,2001,7,,,2008-05-30T22:53:22Z,,0,0,09000064805bb4d8
FDA-2001-P-0125-0001,FDA,FDA-2001-P-0125,FDA/DMB to Ferndale Laboratories Inc.,Other,ACK-Acknowledgement Letter,2001-07-02T04:00:00Z,2001,7,,,2008-04-25T02:26:16Z,,0,0,09000064804dd914
FDA-2001-P-0055-0001,FDA,FDA-2001-P-0055,"FDA/DDM to Ferndale Laboratories, Inc.",Other,ACK-Acknowledgement Letter,2001-07-02T04:00:00Z,2001,7,,,2008-04-25T01:57:35Z,,0,0,09000064804b7e8a
FDA-2020-D-1954-0001,FDA,FDA-2020-D-1954,Small Entity Compliance Guide: Safe Handling Statements on Labeling of Shell Eggs and the Refrigeration of Shell Eggs Held for Retail Distribution,Other,Guidance,2001-07-01T04:00:00Z,2001,7,2020-09-21T04:00:00Z,,2024-11-12T23:24:58Z,,1,0,090000648486938a
FDA-2000-D-0278-0001,FDA,FDA-2000-D-0278,Guidance for Industry: Refusal of Inspection or Access to HACCP Records Pertaining to the Safe and Sanitary Processing of Fish and Fishery Products,Other,Guidance,2001-07-01T04:00:00Z,2001,7,2020-09-29T04:00:00Z,,2024-11-06T23:39:12Z,,1,0,090000648489ae28
FDA-2020-D-1955-0001,FDA,FDA-2020-D-1955,"Small Entity Compliance Guide: Serving Sizes Reference Amount for Baking Powder, Baking Soda, and Pectin",Other,Guidance,2001-07-01T04:00:00Z,2001,7,2020-09-21T04:00:00Z,,2024-11-06T23:39:28Z,,1,0,090000648486938c
FDA-1980-N-0074-0072,FDA,FDA-1980-N-0074,HFD-560 to Warner Lambert Consumer Healthcare,Other,LET-Letter,2001-06-28T04:00:00Z,2001,6,,,2008-05-30T22:53:09Z,,0,0,09000064805bb4d7
FDA-2001-P-0088-0001,FDA,FDA-2001-P-0088,FDA/DDM to the Weinberg Group Inc.,Other,ACK-Acknowledgement Letter,2001-06-26T04:00:00Z,2001,6,,,2008-04-25T02:24:43Z,,0,0,09000064804b8615
FDA-2001-P-0124-0001,FDA,FDA-2001-P-0124,FDA/DDM to GlaxoSmithKline,Other,ACK-Acknowledgement Letter,2001-06-14T04:00:00Z,2001,6,,,2008-04-25T02:25:49Z,,0,0,09000064804dd8dc
FDA-2001-P-0193-0001,FDA,FDA-2001-P-0193,"FDA/DDM to Mallinckrodt, Inc.",Other,ACK-Acknowledgement Letter,2001-05-30T04:00:00Z,2001,5,,,2008-04-25T02:27:23Z,,0,0,09000064804e2a9e
FDA-2001-P-0086-0001,FDA,FDA-2001-P-0086,FDA/DDM to Washington Legal Foundation,Other,ACK-Acknowledgement Letter,2001-05-30T04:00:00Z,2001,5,,,2008-04-25T02:23:19Z,,0,0,09000064804b8533
FDA-2001-P-0090-0001,FDA,FDA-2001-P-0090,"FDA/DDM to Devices & Diagnostics Consulting Group, Inc.",Other,ACK-Acknowledgement Letter,2001-05-17T04:00:00Z,2001,5,,,2008-04-25T02:24:05Z,,0,0,09000064804b89a6
FDA-1998-P-0046-0002,FDA,FDA-1998-P-0046,FDA/CDRH to Levin Fishbein Sedran & Berman,Other,PDN-Petition Denial,2001-05-16T04:00:00Z,2001,5,,,2008-05-16T21:47:38Z,,0,0,090000648056e6f7
FDA-1998-P-0018-0004,FDA,FDA-1998-P-0018,Citizen Petition Denial from FDA CDER to King & Spalding,Other,Denial of Petition,2001-05-10T04:00:00Z,2001,5,,,2024-07-12T16:59:04Z,,0,0,0900006480563c55
FDA-2000-P-0024-0003,FDA,FDA-2000-P-0024,FDA/CDER to Pharmaceutical Associates Inc,Other,PDN-Petition Denial,2001-05-10T04:00:00Z,2001,5,,,2008-04-25T01:13:49Z,,0,0,09000064804aea00
FDA-2000-P-0212-0002,FDA,FDA-2000-P-0212,FDA/CDER to New Jersey General Assembly,Other,LET-Letter,2001-05-08T04:00:00Z,2001,5,,,2008-04-25T01:47:09Z,,0,0,09000064804d4d8f
FDA-2001-P-0030-0001,FDA,FDA-2001-P-0030,Acknowledgement Letter to Duramed Pharmaceuticals Inc.,Other,ACK-Acknowledgement Letter,2001-05-02T04:00:00Z,2001,5,,,2010-03-11T23:01:24Z,,0,0,09000064804b602e
FDA-2001-P-0056-0002,FDA,FDA-2001-P-0056,"FDA/DDM to Pharmaceutical Associates, Inc.",Other,ACK-Acknowledgement Letter,2001-04-25T04:00:00Z,2001,4,,,2008-04-25T01:57:35Z,,0,0,09000064804b7ec7
FDA-2001-P-0239-0001,FDA,FDA-2001-P-0239,"Citizen Petition from Krislov & Associates, LTD.",Other,Citizen Petition,2001-04-23T04:00:00Z,2001,4,2020-07-06T04:00:00Z,,2024-07-29T20:36:46Z,,0,0,09000064804e67f9
FDA-2001-P-0239-0002,FDA,FDA-2001-P-0239,"Acknowledgment Letter from FDA DMB to Krislov & Associates, LTD.",Other,Acknowledgement Letter/Receipt,2001-04-23T04:00:00Z,2001,4,2020-07-06T04:00:00Z,,2024-09-09T17:21:36Z,,0,0,09000064804e680d
FDA-2000-D-0067-0002,FDA,FDA-2000-D-0067,Guidance on Medical Device Patient Labeling:  Final Guidance for Industry and FDA Staff,Other,Guidance,2001-04-19T04:00:00Z,2001,4,2001-04-19T04:00:00Z,,2024-11-11T21:01:40Z,,1,0,0900006481b68183
FDA-1999-D-0188-0002,FDA,FDA-1999-D-0188,Guidance for Industry Effect of Anthelmintics : Specific Recommendations for Ovine  VICH GL13 -  Final Guidance 96,Other,Guidance,2001-04-11T04:00:00Z,2001,4,2001-03-26T05:00:00Z,,2020-04-30T19:51:36Z,,0,0,09000064804b04a6
FDA-1999-D-0188-0001,FDA,FDA-1999-D-0188,Guidance for Industry  Effectiveness of Anthelmintics: Specific Recommendations for Bovine VICH GL12 - Final Guidance 95,Other,Guidance,2001-04-11T04:00:00Z,2001,4,2001-03-26T05:00:00Z,,2020-04-30T19:50:46Z,,0,0,09000064804b04a5
FDA-1999-D-0188-0003,FDA,FDA-1999-D-0188,Guidance for Industry  Effect of Anthelmintics : Specific Recommendations for Caprine VICH GL14 -  Final Guidance 97,Other,Guidance,2001-04-11T04:00:00Z,2001,4,2001-03-26T05:00:00Z,,2020-04-30T19:52:20Z,,0,0,09000064804b04a8
FDA-2000-P-0096-0003,FDA,FDA-2000-P-0096,FDA/CDER to Arnold & Porter,Other,LET-Letter,2001-04-09T04:00:00Z,2001,4,,,2008-04-25T01:01:16Z,,0,0,09000064804b822d
FDA-2001-P-0214-0001,FDA,FDA-2001-P-0214,FDA/DDM to Veigh Hogan Jr.,Other,ACK-Acknowledgement Letter,2001-04-03T04:00:00Z,2001,4,,,2008-04-25T02:37:12Z,,0,0,09000064804e4703
FDA-2001-P-0189-0001,FDA,FDA-2001-P-0189,FDA/CDER to Abbott Laboratories,Other,ACK-Acknowledgement Letter,2001-03-21T05:00:00Z,2001,3,,,2008-04-25T02:27:15Z,,0,0,09000064804e23fa
FDA-2001-P-0056-0001,FDA,FDA-2001-P-0056,"FDA/DDM to Pharmaceutical Associates, Inc.",Other,ACK-Acknowledgement Letter,2001-03-16T05:00:00Z,2001,3,,,2008-04-25T01:57:35Z,,0,0,09000064804b7ebe
FDA-2001-D-0506-0002,FDA,FDA-2001-D-0506,Draft Guidance for Industry on Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines; Guidance Document,Other,Guidance,2001-03-09T05:00:00Z,2001,3,,,2024-11-07T21:53:22Z,,1,0,09000064804ef97f
FDA-2001-P-0216-0001,FDA,FDA-2001-P-0216,"FDA/DDM to Paul, Hastings, Janofsky & Walker LLP",Other,ACK-Acknowledgement Letter,2001-03-08T05:00:00Z,2001,3,,,2008-04-25T02:38:56Z,,0,0,09000064804e4970
FDA-2001-P-0194-0001,FDA,FDA-2001-P-0194,FDA/DDM to Dade Behring Inc.,Other,ACK-Acknowledgement Letter,2001-03-06T05:00:00Z,2001,3,,,2008-04-25T02:38:06Z,,0,0,09000064804e2bef
FDA-2001-P-0001-0001,FDA,FDA-2001-P-0001,FDA/DDM to Mutual Pharmaceutical Company. Inc.,Other,ACK-Acknowledgement Letter,2001-03-06T05:00:00Z,2001,3,,,2008-04-25T02:25:38Z,,0,0,09000064804b3a7a
FDA-2001-P-0156-0001,FDA,FDA-2001-P-0156,FDA/DDM to Tom Stothoff,Other,ACK-Acknowledgement Letter,2001-02-02T05:00:00Z,2001,2,,,2008-04-25T02:25:53Z,,0,0,09000064804df23f
FDA-2000-D-0598-0005,FDA,FDA-2000-D-0598,FDA GeneTox Network to Dockets Management - Memorandum,Other,Memorandum,2001-01-23T05:00:00Z,2001,1,2013-01-23T05:00:00Z,,2013-01-23T19:10:07Z,,0,0,09000064804dd8b3